Hikma Pharmaceuticals PLC (HIK.L)

1.778,00 -11,00 (-0,61%) Ab 01:04PM BST. Markt geöffnet.

Hikma Pharmaceuticals PLC

1 New Burlington Place
London W1S 2HR
United Kingdom
44 20 7399 2760
https://www.hikma.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 9.100

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Engineer Said Samih Taleb Darwazah	Executive Chairman	2,25M	N/A	1957
Mr. Riad Ali Mishlawi	CEO & Director	885,68k	N/A	1964
Mr. Mazen Samih Taleb Darwazah	Executive Vice Chairman & President of MENA	1,85M	N/A	1958
Mr. Khalid Waleed Hosny Al Nabilsi	Chief Financial Officer	N/A	N/A	1972
Patricia Bousfield	Chief Information Officer	N/A	N/A	N/A
Mr. Guy Featherstone	Associate Director of Investor Relations	N/A	N/A	N/A
Mr. Samuel Park	General Counsel	N/A	N/A	N/A
Mr. Bassam Wael Rushdi Kanaan CFA, CPA	Executive Vice President of Corporate Development and M&A	N/A	N/A	1965
Mr. Hussein Omar Arkhagha	Chief People Officer	N/A	N/A	N/A
Ms. Susan Ringdal	Executive Vice President of Strategic Planning & Global Affairs	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Corporate Governance

Hikma Pharmaceuticals PLCs ISS Governance QualityScore, Stand 1. April 2024, lautet 7. Die grundlegenden Scores sind Audit: 6, Vorstand: 9, Shareholderrechte: 7, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.